Cargando…
An Experience with Managing Cancer Patients Reportedly Previously Informed of the Absence of Additional Available Antineoplastic Therapeutic Options
Over the past 5 years, a small group of cancer patients who stated their physicians had determined there were no additional available antineoplastic therapeutic options (including potential investigational strategies) were seen for a ‘second opinion’ in a cancer hospital-based oncology program and s...
Autores principales: | River, George, Moore, Stephanie, Tucker, Jennifer, Markman, Maurie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209267/ https://www.ncbi.nlm.nih.gov/pubmed/25408656 http://dx.doi.org/10.1159/000367793 |
Ejemplares similares
-
Management of Two Cases of Recurrent Anal Carcinoma
por: Klimant, Eiko, et al.
Publicado: (2013) -
Is It Time to Inform This Patient that Further Antineoplastic Drug Therapy Will Not Be of Clinical Value?
por: Markman, Maurie
Publicado: (2010) -
Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
por: Chen, Jian, et al.
Publicado: (2009) -
Cyclophosphamide-Induced Severe Acute Hyponatremic Encephalopathy in Patients with Breast Cancer: Report of Two Cases
por: Baker, Michelle, et al.
Publicado: (2014) -
Pegylated Liposomal Doxorubicin-Induced Acute Transient Encephalopathy in a Patient with Breast Cancer: A Case Report
por: Baker, Michelle, et al.
Publicado: (2014)